Comparing COVID-19 Vaccination Coverage, Adverse Reactions and Impact of Social Determinants of Health on Vaccine Hesitancy in ADRD/MCI and Non-ADRD/MCI Population: Protocol for a Retrospective Cross-sectional Study

Overview

Journal BMJ Open

Specialty General Medicine

Date 2024 Jul 16

PMID 39013656

Authors

Yijiong Yang

Hyejin Park

Chengdong Li

Dan Song

Jing Wang

Affiliations

Soon will be listed here.

Abstract

Introduction: COVID-19 vaccination is crucial for vulnerable people with underlying chronic conditions such as Alzheimer's disease and related dementias (ADRD) and mild cognitive impairment (MCI). These individuals face unique challenges, including higher risk of COVID-19, difficulties in adopting preventive behaviours and vaccine hesitancy due to concerns about adverse reactions. Therefore, efforts to promote vaccination, including boosters tailored to the currently circulating virus, are essential for people with ADRD/MCI.

Objective: The primary purpose of this study protocol is to conduct a comprehensive analysis of COVID-19 vaccination coverage and adverse reactions among individuals with ADRD/MCI in comparison to those without ADRD/MCI. Additionally, the proposed study aims to investigate the impact of social determinants of health on COVID-19 vaccination and vaccine hesitancy in individuals with ADRD/MCI.

Methods And Analysis: A retrospective cross-sectional study will be conducted utilising data from the ) Researcher Workbench. Relevant data fields are extracted from sources including demographic information, COVID-19 Vaccine Survey, Basic Survey, Health Access & Utilization, Social Determinants of Health, and Electronic Health Record (EHR) data. Data on vaccination, adverse reactions and vaccine hesitancy will be collected through COVID-19 vaccine survey questionnaires. Propensity score matching and binary logistic regression will be applied to assess the vaccination rates and vaccine hesitancy, while controlling for demographic characteristics and social determinants of health factors.

Ethics And Dissemination: This study protocol received approval from the Institutional Review Board at Florida State University (STUDY00004571). Results will be disseminated through publication in peer-reviewed journals and presented at scientific conferences.

References

Chen R, Charpignon M, Raquib R, Wang J, Meza E, Aschmann H . Excess Mortality With Alzheimer Disease and Related Dementias as an Underlying or Contributing Cause During the COVID-19 Pandemic in the US. JAMA Neurol. 2023; 80(9):919-928. PMC: 10352932. DOI: 10.1001/jamaneurol.2023.2226. View

Rolland Y, Baziard M, de Mauleon A, Dubus E, Saidlitz P, Soto M . Coronavirus Disease-2019 in Older People with Cognitive Impairment. Clin Geriatr Med. 2022; 38(3):501-517. PMC: 8934719. DOI: 10.1016/j.cger.2022.03.002. View

Brown C, Young S, Pro G . COVID-19 vaccination rates vary by community vulnerability: A county-level analysis. Vaccine. 2021; 39(31):4245-4249. PMC: 8215509. DOI: 10.1016/j.vaccine.2021.06.038. View

Pszczolowska M, Walczak K, Miskow W, Antosz K, Batko J, Karska J . Molecular cross-talk between long COVID-19 and Alzheimer's disease. Geroscience. 2024; 46(3):2885-2899. PMC: 11009207. DOI: 10.1007/s11357-024-01096-1. View

Su Z, McDonnell D, Li Y . Why is COVID-19 more deadly to nursing home residents?. QJM. 2021; 114(8):543-547. PMC: 7928659. DOI: 10.1093/qjmed/hcaa343. View

Mazereel V, Vanbrabant T, Desplenter F, Detraux J, De Picker L, Thys E . COVID-19 Vaccination Rates in a Cohort Study of Patients With Mental Illness in Residential and Community Care. Front Psychiatry. 2022; 12:805528. PMC: 8716918. DOI: 10.3389/fpsyt.2021.805528. View

Wang L, Davis P, Kaelber D, Xu R . COVID-19 breakthrough infections and hospitalizations among vaccinated patients with dementia in the United States between December 2020 and August 2021. Alzheimers Dement. 2022; 19(2):421-432. PMC: 9073984. DOI: 10.1002/alz.12669. View

. 2024 Alzheimer's disease facts and figures. Alzheimers Dement. 2024; 20(5):3708-3821. PMC: 11095490. DOI: 10.1002/alz.13809. View

Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz M . BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. N Engl J Med. 2021; 384(15):1412-1423. PMC: 7944975. DOI: 10.1056/NEJMoa2101765. View

10.

Malik A, McFadden S, Elharake J, Omer S . Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020; 26:100495. PMC: 7423333. DOI: 10.1016/j.eclinm.2020.100495. View

11.

Taylor L . Covid-19: Vaccination reduces severity and duration of long covid, study finds. BMJ. 2023; 380:491. DOI: 10.1136/bmj.p491. View

12.

Yang Y, Nie J, Sun F, Wang J, Chen J, Li L . The SARS-CoV-2 vaccination rate and hesitation in Shanghai older adults with dementia. Front Public Health. 2023; 11:1172642. PMC: 10335564. DOI: 10.3389/fpubh.2023.1172642. View

13.

MacCallum-Bridges C, Hirschtick J, Patel A, Orellana R, Elliott M, Fleischer N . The impact of COVID-19 vaccination prior to SARS-CoV-2 infection on prevalence of long COVID among a population-based probability sample of Michiganders, 2020-2022. Ann Epidemiol. 2024; 92:17-24. DOI: 10.1016/j.annepidem.2024.02.007. View

14.

Du X, Song L, Schulz P, Xu H, Chan W . Risk of Developing Alzheimer's Disease and Related Dementias in Association with Cardiovascular Disease, Stroke, Hypertension, and Diabetes in a Large Cohort of Women with Breast Cancer and with up to 26 Years of Follow-Up. J Alzheimers Dis. 2022; 87(1):415-432. PMC: 9117151. DOI: 10.3233/JAD-215657. View

15.

Hardan L, Filtchev D, Kassem R, Bourgi R, Lukomska-Szymanska M, Tarhini H . COVID-19 and Alzheimer's Disease: A Literature Review. Medicina (Kaunas). 2021; 57(11). PMC: 8625592. DOI: 10.3390/medicina57111159. View

16.

Khubchandani J, Sharma S, Price J, Wiblishauser M, Sharma M, Webb F . COVID-19 Vaccination Hesitancy in the United States: A Rapid National Assessment. J Community Health. 2021; 46(2):270-277. PMC: 7778842. DOI: 10.1007/s10900-020-00958-x. View

17.

Kelley K, Maxwell S . Sample size for multiple regression: obtaining regression coefficients that are accurate, not simply significant. Psychol Methods. 2003; 8(3):305-21. DOI: 10.1037/1082-989X.8.3.305. View

18.

Baden L, El Sahly H, Essink B, Kotloff K, Frey S, Novak R . Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2020; 384(5):403-416. PMC: 7787219. DOI: 10.1056/NEJMoa2035389. View

19.

Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S . Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020; 396(10248):413-446. PMC: 7392084. DOI: 10.1016/S0140-6736(20)30367-6. View

20.

Austin P . An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivariate Behav Res. 2011; 46(3):399-424. PMC: 3144483. DOI: 10.1080/00273171.2011.568786. View